MedDay is a biotechnology company, which develops new drugs for neurological and psychiatric diseases. It provides MD1003, a solution for the treatment of primary and secondary progressive multiple sclerosis; MD1103, a solution for autism spectrum disorders; and MD1105, a solution for Alzheimer’s disease.
|Employees (est.) (Jan 2020)||94||(-1%)|
MedDay total Funding
MedDay latest funding size
Time since last funding
|4 years ago|
|Sofinnova Partners, Bpifrance Large Venture, Edmond de Rothschild Investment Partners, InnoBio|
MedDay has 221 Twitter Followers. The number of followers has increased 2% month over month and increased 2.8% quarter over quarter
When was MedDay founded?
MedDay was founded in 2011.
Who are MedDay key executives?
MedDay's key executives are Delphine Bernard, Hermine Cadence and Audrey Cristofani.
How many employees does MedDay have?
MedDay has 94 employees.
Who are MedDay competitors?
Competitors of MedDay include ImCheck Therapeutics, Rubius Therapeutics and Atara Biotherapeutics.
Where is MedDay headquarters?
MedDay headquarters is located at 24 Rue de la Pépinière, Paris.
Where are MedDay offices?
MedDay has an office in Paris.
How many offices does MedDay have?
MedDay has 1 office.
Receive alerts for 300+ data fields across thousands of companies